GB0817585D0 - Novel compositions and methods - Google Patents

Novel compositions and methods

Info

Publication number
GB0817585D0
GB0817585D0 GB0817585A GB0817585A GB0817585D0 GB 0817585 D0 GB0817585 D0 GB 0817585D0 GB 0817585 A GB0817585 A GB 0817585A GB 0817585 A GB0817585 A GB 0817585A GB 0817585 D0 GB0817585 D0 GB 0817585D0
Authority
GB
United Kingdom
Prior art keywords
methods
novel compositions
compositions
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0817585A
Other versions
GB2463883A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaPatents Global Ltd
Original Assignee
PHARMA PATENTS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMA PATENTS Ltd filed Critical PHARMA PATENTS Ltd
Priority to GB0817585A priority Critical patent/GB2463883A/en
Publication of GB0817585D0 publication Critical patent/GB0817585D0/en
Priority to PCT/GB2009/051262 priority patent/WO2010035047A1/en
Publication of GB2463883A publication Critical patent/GB2463883A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
GB0817585A 2008-09-25 2008-09-25 A pharmaceutical composition comprising an A-SMase inhibitor and an NO-donor Withdrawn GB2463883A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0817585A GB2463883A (en) 2008-09-25 2008-09-25 A pharmaceutical composition comprising an A-SMase inhibitor and an NO-donor
PCT/GB2009/051262 WO2010035047A1 (en) 2008-09-25 2009-09-25 Binary compositions comprising an no-donor and an a-smase inhibitor for the treatment of respiratory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0817585A GB2463883A (en) 2008-09-25 2008-09-25 A pharmaceutical composition comprising an A-SMase inhibitor and an NO-donor

Publications (2)

Publication Number Publication Date
GB0817585D0 true GB0817585D0 (en) 2008-11-05
GB2463883A GB2463883A (en) 2010-03-31

Family

ID=40019565

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0817585A Withdrawn GB2463883A (en) 2008-09-25 2008-09-25 A pharmaceutical composition comprising an A-SMase inhibitor and an NO-donor

Country Status (2)

Country Link
GB (1) GB2463883A (en)
WO (1) WO2010035047A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112724103A (en) * 2020-12-16 2021-04-30 广安凯特制药有限公司 Isopromazine specific impurity and analysis method and removal method thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104610130A (en) * 2015-01-22 2015-05-13 华东理工常熟研究院有限公司 Amlodipine-palmic acid ionic liquid as well as preparation method and application thereof
US11517557B2 (en) 2017-07-13 2022-12-06 Tonix Pharmaceuticals Holding Corp. Analogs of cyclobenzaprine and amitriptyline
WO2020163966A1 (en) * 2019-02-14 2020-08-20 Algernon Pharmaceuticals Inc. Compositions and methods for treating idiopathic pulmonary fibrosis
KR102422449B1 (en) * 2019-10-18 2022-07-20 연세대학교 산학협력단 A composition for preventing, alleviating or treating tuberculosis and infected disease by nontuberculous mycobacteria
CN111008486B (en) * 2019-12-27 2022-11-01 中国矿业大学 Method for cutting coal wall and counting lump coal rate by 2D simulation fully-mechanized face roller
CN112457358B (en) * 2020-12-11 2022-05-31 上海交通大学 Compound, nitric oxide donor prodrug compound, preparation method and application thereof
CN113730409B (en) * 2021-11-01 2022-06-14 济南市中心医院 Application of quinacrine in preparation of medicine for treating pulmonary fibrosis
CN116675620A (en) * 2022-02-22 2023-09-01 东南大学 NO donor compound, preparation method, pharmaceutical composition and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133584T4 (en) * 1990-12-05 2009-11-19 The General Hospital Corp., Boston Apparatus for treating a pulmonary constriction and asthma
DE19519056A1 (en) * 1995-05-24 1997-01-16 Klinge Co Chem Pharm Fab Use of antidepressants for the treatment of asthma and / or respiratory diseases by inhalation
US7279176B1 (en) * 1999-09-02 2007-10-09 Rice University Nitric oxide-producing hydrogel materials
AU2002310511B2 (en) * 2001-07-09 2007-12-06 Combinatorx, Incorporated Combinations for the treatment of inflammatory disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112724103A (en) * 2020-12-16 2021-04-30 广安凯特制药有限公司 Isopromazine specific impurity and analysis method and removal method thereof

Also Published As

Publication number Publication date
GB2463883A (en) 2010-03-31
WO2010035047A1 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
IL210153A0 (en) Nutrigenomics methods and compositions
IL212822A0 (en) Anti-cxcr1 compositions and methods
GB0815872D0 (en) Novel method and compositions
ZA201001300B (en) Antigen-asjuvant compositions and methods
PL2137210T3 (en) Novel method and compositions
GB0819530D0 (en) Methods and compositions
FI3812360T3 (en) Monochlorotrifluoropropene compounds and compositions and methods using same
EP2334804A4 (en) Co-culture compositions and methods
IL210559A0 (en) Novel compositions and methods
IL210588A0 (en) Novel compositions and methods
GB0721291D0 (en) Methods and compositions
GB0817585D0 (en) Novel compositions and methods
GB0809912D0 (en) Novel compositions and uses thereof
GB0719526D0 (en) Compositions and methods
GB0901494D0 (en) Compositions and Methods
SI2320888T1 (en) Laidlomycin compositions and methods
GB0811250D0 (en) Methods and compositions
GB0811152D0 (en) Methods and compositions
GB0803464D0 (en) Methods and compositions
GB0818399D0 (en) Methods and compositions
GB0816534D0 (en) Compositions and methods
GB0802079D0 (en) Method and compositions
GB0723775D0 (en) Methods and compositions
GB0724549D0 (en) Compositions and methods
GB0717683D0 (en) Compositions and methods

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: PHARMAPATENTS GLOBAL LTD

Free format text: FORMER OWNER: PHARMA PATENTS LTD

WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)